-
-
公开(公告)号：KR1020140088401A
公开(公告)日：2014-07-10
申请号：KR1020130000235
申请日：2013-01-02
Applicant: 조선대학교산학협력단
CPC classification number: C12P19/02
Abstract: The present invention relates to a glycosylation method of a non-degradable substance of seaweed using a marine invertebrate herbivore intestine-derived coenzyme. According to the glycosylation method, a sugar component of the seaweed can be effectively separated and used by glycosylating at high efficiency, the non-gradable seaweed substances which were not efficiently used before.
Abstract translation: 本发明涉及使用海洋无脊椎动物食草动物肠衍生辅酶的海藻不可降解物质的糖基化方法。 根据糖基化方法，通过高效糖基化可以有效地分离和使用海草中的糖成分，以前没有有效使用的不可分级的海藻物质。
-
3.发明授权
公开(公告)号：KR101322478B1
公开(公告)日：2013-10-29
申请号：KR1020110092951
申请日：2011-09-15
Applicant: 조선대학교산학협력단
IPC: A61K35/618 , A61K35/38 , A61K38/01 , A61K9/14
Abstract: 본 발명은 MMP(Matrix metalloproteinases: 이하, 'MMP'라 함) 활성 억제 효과를 갖는 전복 내장 위장관 소화가수분해물(Abalone intestine gastro-intestinal digests: AIGID) 및 이를 유효성분으로 함유하는 MMP-2, MMP-9 활성 억제용 약학 조성물에 관한 것으로, 이들은 MMP 활성과 관련된 질환, 예컨대 암, 신경퇴행성, 심혈관 및 다양한 종류의 염증 질환을 포함한 질환을 예방 또는 치료할 수 있는 유익한 효과를 갖는다.
-
4.发明公开
公开(公告)号：KR1020130029598A
公开(公告)日：2013-03-25
申请号：KR1020110092952
申请日：2011-09-15
Applicant: 조선대학교산학협력단
Abstract: PURPOSE: A hot water extract of abalone is provided to ensure excellent antioxidation without side effects and to suppress angiotensin I converting enzyme. CONSTITUTION: A hot water extract of abalone is prepared by desalting abalone-boiled water, filtering using an ultrafilter, and freeze-drying. A pharmaceutical composition for preventing or treating hypertension contains 0.01-99 wt% of the hot water extract as an active ingredient. A health functional food for treating hypertension contains the hot water extract as an active ingredient. [Reference numerals] (AA) ACE inhibition activity(%); (BB) Concentration(ug/mL)
Abstract translation: 目的：提供鲍鱼的热水提取物，以确保优异的抗氧化，无副作用，并抑制血管紧张素I转化酶。 规定：鲍鱼的热水提取物是通过使鲍鱼开水脱盐，使用超滤器过滤和冷冻干燥来制备的。 用于预防或治疗高血压的药物组合物含有0.01-99重量％的热水提取物作为活性成分。 用于治疗高血压的健康功能食品含有热水提取物作为活性成分。 （AA）ACE抑制活性（％） （BB）浓度（ug / mL）
-
5.发明公开해양 미세조류의 바이오디젤 부산물로부터 분리된 펩티드를 유효성분으로 함유하는 고혈압의 예방 또는 치료용 약학적 조성물 无效用于预防或治疗包含海洋微生物生物多样性分离的肽的高血压药物组合物
公开(公告)号：KR1020140096194A
公开(公告)日：2014-08-05
申请号：KR1020130000237
申请日：2013-01-02
Applicant: 조선대학교산학협력단
CPC classification number: A61K38/08 , A23L33/18 , A61K38/005 , A61K38/012 , C07K7/06 , Y10S530/80
Abstract: The present invention relates to a pharmaceutical composition comprising a peptide isolated from biodiesel byproducts of marine microalgae as an active ingredient for preventing or treating hypertension, and a functional health food comprising the active ingredient. The pharmaceutical composition and the functional health food, according to the present invention, show inhibitory activity for angiotensin I converting enzyme (ACE), thereby having an excellent effect for preventing or treating hypertension.
Abstract translation: 本发明涉及包含从海洋微藻的生物柴油副产物分离的肽作为预防或治疗高血压的活性成分的药物组合物和包含活性成分的功能性保健食品。 根据本发明的药物组合物和功能保健食品显示对血管紧张素I转化酶（ACE）的抑制活性，从而具有优异的预防或治疗高血压的效果。
-
Patent Agency Ranking6.发明公开
公开(公告)号：KR1020140088403A
公开(公告)日：2014-07-10
申请号：KR1020130000238
申请日：2013-01-02
Applicant: 조선대학교산학협력단
CPC classification number: A61K38/08 , A23L33/105 , A61K35/747 , A61K36/03 , A61K2236/19
Abstract: The present invention relates to a pharmaceutical composition containing peptide separated from a fermented product of marine microalgae as an active ingredient for preventing or treating bone diseases and a health functional food including the active ingredient. The pharmaceutical composition and health functional food according to the present invention performs a function of promoting the differentiation of osteoblasts so that bone diseases such as osteoporosis are prevented or treated.
Abstract translation: 本发明涉及含有作为预防或治疗骨病的活性成分的海洋微藻发酵物分离出的肽的药物组合物和包含活性成分的保健功能性食品。 根据本发明的药物组合物和保健功能食品具有促进成骨细胞分化的功能，从而防止或治疗骨质疏松等骨疾病。
-
7.发明公开해양 미세조류의 바이오디젤 부산물로부터 분리된 펩티드를 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학적 조성물 无效用于预防或治疗包含从生物体分离的肽的骨髓疾病的药物组合物海洋微藻的产品
公开(公告)号：KR1020140088402A
公开(公告)日：2014-07-10
申请号：KR1020130000236
申请日：2013-01-02
Applicant: 조선대학교산학협력단
CPC classification number: A61K38/1767 , A23L33/18 , A61K36/02 , C07K14/405
Abstract: The present invention relates to a pharmaceutical composition containing peptide separated from a biodiesel byproduct of marine microalgae as an active ingredient for preventing or treating bone diseases and a health functional food including the active ingredient. The pharmaceutical composition and health functional food according to the present invention performs a function of promoting the differentiation of osteoblasts so that bone diseases such as osteoporosis are prevented or treated.
Abstract translation: 本发明涉及从海洋微藻的生物柴油副产物分离出的肽作为预防或治疗骨病的活性成分的药物组合物和包含活性成分的保健功能性食品。 根据本发明的药物组合物和保健功能食品具有促进成骨细胞分化的功能，从而防止或治疗骨质疏松等骨疾病。
-
公开(公告)号：KR101322477B1
公开(公告)日：2013-10-29
申请号：KR1020110092952
申请日：2011-09-15
Applicant: 조선대학교산학협력단
Abstract: 본 발명은 전복을 가공하는 과정에서 발생하는 부산물인 전복 삶은 물의 항산화 및 ACE 억제 효과를 밝히고, 이를 함유한 약학 조성물 및 기능성 건강식품 조성물을 제공하는 발명에 관한 것으로, 합성 의약품의 부작용을 갖지 않으므로 장기 복용이 가능하고, 가공 부산물을 사용하므로 원가비 절감이라는 유익한 효과를 갖는다.
-
9.发明公开ＭＭＰ 활성 억제 효과를 갖는 전복 내장 위장관 소화가수분해물 및 이를 유효성분으로 함유하는 약학 조성물 有权具有抑制MMP活性的作用的ABALONE INTESTINE GASTRO-INTESTINAL DIGESTS和含有其作为活性成分的药物组合物
公开(公告)号：KR1020130029597A
公开(公告)日：2013-03-25
申请号：KR1020110092951
申请日：2011-09-15
Applicant: 조선대학교산학협력단
IPC: A61K35/618 , A61K35/38 , A61K38/01 , A61K9/14
CPC classification number: A61K35/618 , A61K9/14 , A61K35/38 , A61K38/012
Abstract: PURPOSE: An abalone intestine gastro-intestinal digest and a pharmaceutical composition are provided to prevent or treat diseases including cancer, neurodegeneration, and various inflammatory diseases. CONSTITUTION: An abalone intestine gastro-intestinal digest suppresses matrix metalloproteinases-2 or matrix metalloproteinases-9 activity. A pharmaceutical composition for suppressing matrix metalloproteinases-2 or matrix metalloproteinases-9 activity contains 0.01-99.9 wt% of the abalone intestine gastro-intestinal digest as an active ingredient. [Reference numerals] (AA) Control group
Abstract translation: 目的：提供一种鲍鱼肠胃消化和药物组合物，用于预防或治疗包括癌症，神经退行性疾病和各种炎性疾病的疾病。 构成：鲍鱼肠胃消化抑制基质金属蛋白酶-2或基质金属蛋白酶-9活性。 用于抑制基质金属蛋白酶-2或基质金属蛋白酶-9活性的药物组合物含有0.01-99.9重量％的鲍鱼肠胃消化物作为活性成分。 （标号）（AA）对照组
-
公开(公告)号：KR1020130029595A
公开(公告)日：2013-03-25
申请号：KR1020110092949
申请日：2011-09-15
Applicant: 조선대학교산학협력단
CPC classification number: A23L33/10 , A23L33/135 , A23V2002/00 , A23V2200/30 , A23V2250/202
Abstract: PURPOSE: A microalgae fermentation is provided to enhance antioxidation by fermenting Haptophyceae with Hansenula polymorpha. CONSTITUTION: A microalgae fermentation is prepared by fermenting Haptophyceae with Hansenula polymorpha and freeze-drying the fermented microalgae. The microalgae fermentation has an antioxidative activity in vivo. A pharmaceutical composition with an antioxidative activity contains 0.01-99 wt% of the microalgae fermentation as an active ingredient. A health functional composition with an antioxidative activity contains the microalgae fermentation as an active ingredient. [Reference numerals] (AA) Scavenging activity(%); (BB) Concentration(mg/mL)
Abstract translation: 目的：提供微藻发酵，以通过多发性汉逊酵母发酵哈皮菌素来增强抗氧化作用。 构成：通过用汉逊酵母（Hansenula polymorpha）发酵Haptophyceae并冷冻干燥发酵的微藻来制备微藻发酵。 微藻发酵体内具有抗氧化活性。 具有抗氧化活性的药物组合物含有0.01-99重量％的微藻发酵作为活性成分。 具有抗氧化活性的健康功能组合物含有微藻发酵作为活性成分。 （AA）清除活性（％） （BB）浓度（mg / mL）
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.069 seconds)
